ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00526617
Recruitment Status : Completed
First Posted : September 10, 2007
Last Update Posted : November 21, 2017
Sponsor:
Information provided by (Responsible Party):
AbbVie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2010
  Study Completion Date : No date given